Scantek and Medilead in Distribution Alliance

(Cedar Knolls, NJ, USA) has entered into a distribution agreement with Medilead in which Scantek granted Medilead (Ljubljana, Slovenia) an exclusive, perpetual license to distribute the BreastCare/BreastAlert differential temperature sensor device in Bosnia-Herzegovina, Bulgaria, Croatia, Macedonia, Montenegro, Serbia, and Slovenia.

Medilead is a medical sales company based in Central Europe. Scantek is a high-tech medical company engaged in developing, manufacturing, selling, and licensing of products and devices to assist in the early detection and diagnosis of disease. Initially, Scantek intends to focus upon manufacturing, selling, and licensing the BreastCare device. The BreastCare device is to be used by clinicians as an adjunct to clinical breast examination, mammography, and other established techniques for the detection of breast disease.

This system can considerably improve early detection of breast cancer when used as an adjunct to clinical breast examination and mammography. In clinical studies in the United States (i.e., Memorial Sloan Kettering Cancer Center [NY, NY, USA], MD Anderson Cancer Center [Houston, TX, USA], the University of California, Los Angeles [USA], as well as and the European Institute of Oncology [Milan, Italy]), the BreastCare system has been clinically proven capable of recognizing metabolic activity (angiogenesis) by recording the heat differentiation of corresponding areas of the breast. At the present time, in developing countries, as well as industrial nations, there is no available screening procedure which identifies increased metabolic activity due to abnormal cell proliferation.





Related Links:
Scantek Medical
Medilead